The AIR-BX2 study enrolled people with non-cystic fibrosis (non-CF) bronchiectasis and gram-negative airway infection. Participants received two 28-day courses of either Aztreonam for Inhalation Solution (AZLI) or placebo taken 3 times a day. Each course was followed by a 28-day off-drug period. Following the two blinded courses, all participants received a 28-day course of open-label AZLI then were followed for an additional 56 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
274
Change in QOL-B Respiratory Symptoms Score at Day 28
The mean (SD) change in the Respiratory Symptoms score on the Quality of Life Questionnaire-Bronchiectasis (QOL-B) was measured from baseline to the end of Course 1 (Day 28). The QOL-B respiratory symptoms score was transformed onto a scale of 0-100, with higher scores representing a better quality of life.
Time frame: Baseline to Day 28
Change in QOL-B Respiratory Symptoms Score at Day 84
The mean (SD) change in the Respiratory Symptoms score on the QOL-B was measured from baseline to the end of Course 2 (Day 84). The QOL-B respiratory symptoms score was transformed onto a scale of 0-100, with higher scores representing a better quality of life.
Time frame: Baseline to Day 84
Time to Protocol-Defined Exacerbation (PDE)
Protocol-defined exacerbation was defined as an acute worsening of respiratory disease that triggered the initiation of a non-study antibiotic meeting at least 3 major criteria, or 2 major and at least 2 minor criteria. * Major Criteria: increased sputum production; increased discoloration of sputum; increased dyspnea; increased cough * Minor Criteria: fever (\> 38º C) measured during clinic visit; increased malaise or fatigue; forced expiratory volume in 1 second (FEV1) (L) or forced vital capacity (FVC) decreased \> 10% from baseline; new or increased hemoptysis
Time frame: Baseline to Day 112
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Florence Research Associates
Florence, Alabama, United States
Clinical Trials Connection
Flagstaff, Arizona, United States
Phoenix Medical Group
Peoria, Arizona, United States
Pulmonary Associates
Phoenix, Arizona, United States
AZ Pulmonary Specialists, LTD
Scottsdale, Arizona, United States
Pulmonary Consultants & Primary Care Physicians Medical Group, Inc.
Orange, California, United States
UC San Diego Medical Center
San Diego, California, United States
California Pacific Medical Center
San Francisco, California, United States
Georgetown University Hospital
Washington D.C., District of Columbia, United States
University of Florida
Jacksonville, Florida, United States
...and 75 more locations